You are in the section for: Colonix Corporate
               

For General Population Screening (asymptomatic)

The ColoGenix™ Screen-View test is now entering the advanced clinical trial phase, and is due for commercial release in late 2010 within the E.U. and late 2011 in the U.S.A.

It is widely understood that in order to reduce CRC based deaths in the future, there is a need for accurate, economical and patient acceptable screening tests.

Further details will be made available soon.

 

equipment required for early detection and screening of colorectal cancer
The Colonix System

Cologenix Screen View colorectal screening test

 

ColoGenix ScreenView Orange Bullet Point

No bowel preparation necessary

ColoGenix ScreenView Orange Bullet Point

Minimal dietary restrictions

ColoGenix ScreenView Orange Bullet Point

For general population screening

ColoGenix ScreenView Orange Bullet Point

Reduce unnecessary further investigations

ColoGenix ScreenView Orange Bullet Point

Fast, simple and painless procedure

ColoGenix ScreenView Orange Bullet Point

Exceptional health economics

ColoGenix ScreenView Orange Bullet Point

Rapid and reliable results - available on-line

ColoGenix ScreenView Orange Bullet Point

Virtually eliminate false negatives

ColoGenix ScreenView Orange Bullet Point

High negative predictive value

ColoGenix ScreenView Orange Bullet Point

High patient acceptance rate
colonix Footer colonix Footer Right